HPIC Stock Overview
Engages in the manufacture and marketing of generic pharmaceutical products in Jordan.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Hayat Pharmaceutical Industries Co. PLC Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | د.أ2.54 |
| 52 Week High | د.أ2.73 |
| 52 Week Low | د.أ2.40 |
| Beta | 0.20 |
| 11 Month Change | 4.10% |
| 3 Month Change | -0.39% |
| 1 Year Change | 2.01% |
| 33 Year Change | -40.79% |
| 5 Year Change | 28.93% |
| Change since IPO | 35.83% |
Recent News & Updates
Recent updates
Shareholder Returns
| HPIC | JO Pharmaceuticals | JO Market | |
|---|---|---|---|
| 7D | 3.3% | -0.8% | -0.9% |
| 1Y | 2.0% | 5.8% | -3.8% |
Return vs Industry: HPIC underperformed the JO Pharmaceuticals industry which returned 5.8% over the past year.
Return vs Market: HPIC exceeded the JO Market which returned -3.8% over the past year.
Price Volatility
| HPIC volatility | |
|---|---|
| HPIC Average Weekly Movement | 3.3% |
| Pharmaceuticals Industry Average Movement | 5.1% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in JO Market | 5.8% |
| 10% least volatile stocks in JO Market | 1.8% |
Stable Share Price: HPIC has not had significant price volatility in the past 3 months.
Volatility Over Time: HPIC's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 236 | Maher Mohammed Al Kurdi | www.hayatpharma.com |
Hayat Pharmaceutical Industries Co. PLC engages in the manufacture and marketing of generic pharmaceutical products in Jordan. It offers products in various therapeutic areas, such as allergies; cardiovascular system; dermatology; gastrointestinal system; infectious disease; inner ear and balance; neurology; pain and inflammation; respiratory system; and vitamins and supplements, as well as men’s and women’s health products. The company was founded in 1994 and is based in Amman, Jordan.
Hayat Pharmaceutical Industries Co. PLC Fundamentals Summary
| HPIC fundamental statistics | |
|---|---|
| Market cap | د.أ24.13m |
| Earnings (TTM) | د.أ2.45m |
| Revenue (TTM) | د.أ15.11m |
9.8x
P/E Ratio1.6x
P/S RatioIs HPIC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HPIC income statement (TTM) | |
|---|---|
| Revenue | د.أ15.11m |
| Cost of Revenue | د.أ5.90m |
| Gross Profit | د.أ9.20m |
| Other Expenses | د.أ6.75m |
| Earnings | د.أ2.45m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.26 |
| Gross Margin | 60.93% |
| Net Profit Margin | 16.24% |
| Debt/Equity Ratio | 7.0% |
How did HPIC perform over the long term?
See historical performance and comparison